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Purpose: Surfactant proteins (SPs) are involved in the regulation of rheological
properties of body fluids. Concentrations of SPs are altered in the cerebrospinal
fluid (CSF) of hydrocephalus patients. The common hallmark of hydrocephalus is
enlargement of the brain ventricles. The relationship of both phenomena has not yet
been investigated. The aim of this study was to evaluate the association between SP
concentrations in the CSF and enlargement of the brain ventricles.
Procedures: Ninty-six individuals (41 healthy subjects and 55 hydrocephalus patients)
were included in this retrospective analysis. CSF specimens were analyzed for SP-A,
SP-B, SP-C and SP-D concentrations by use of enzyme linked immunosorbent
assays (ELISA). Ventricular enlargement was quantified in T2 weighted (T2w) magnetic
resonance imaging (MRI) sections using an uni-dimensional (Evans’ Index) and a
two-dimensional approach (lateral ventricles area index, LVAI).
Results: CSF-SP concentrations (mean ± standard deviation in ng/ml) were as follows:
SP-A 0.71 ± 0.58, SP-B 0.18 ± 0.43, SP-C 0.89 ± 0.77 and SP-D 7.4 ± 5.4.
Calculated values of Evans’ Index were 0.37 ± 0.11, a calculation of LVAI resulted in
0.18 ± 0.15 (each mean ± standard deviation). Significant correlations were identified
for Evans’ Index with SP-A (r = 0.388, p < 0.001) and SP-C (r = 0.392, p < 0.001), LVAI
with SP-A (r = 0.352, p = 0.001), SP-C (r = 0.471, p < 0.001) and SP-D (r = 0.233,
p = 0.025). Furthermore, SP-C showed a clear inverse correlation with age (r = −0.357,
p = 0.011).
Conclusion: The present study confirmed significant correlations between SPs A, C
and D in the CSF with enlargement of the inner CSF spaces. In conclusion, SPs
clearly play an important role for CSF rheology. CSF rheology is profoundly altered in
hydrocephalic diseases, however, diagnosis and therapy of hydrocephalic conditions
are still almost exclusively based on ventricular enlargement. Until now it was unclear,
whether the stage of the disease, as represented by the extent of ventricular dilatation, is
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somehow related to the changes of SP levels in the CSF. Our study is the first to provide
evidence that increasing ventriculomegaly is accompanied by enhanced changes of
rheologically active compounds in the CSF and therefore introduces completely new
aspects for hydrocephalus testing and conservative therapeutic approaches.
Keywords: MRI, surfactant proteins, CSF, ventricular enlargement, Evans’ index
INTRODUCTION
Surfactant proteins (SPs) are a heterogeneous group of proteins
being present at various sites in the body (Snegovskikh et al.,
2011; Yadav et al., 2011; Hallman, 2013). SPs have been
described initially in the respiratory system (Phizackerley et al.,
1979). Two functionally different SP-fractions exist, the collectin
type SPs (SP-A and SP-D) and the hydrophobic SPs (SP-B
and SP-C). Collectin type SPs are soluble pattern-recognition
proteins of the innate immunity, functionally resembling
the antibodies of the adaptive immune system (Palaniyar,
2010). They mostly bear—among other cellular and humoral
components—responsibility for host defense and alleviation of
detrimental immune responses in the lungs (Wright, 2005;
Hallman, 2013). Hydrophobic SPs (SP-B and SP-C) decrease
surface tension of the alveolar fluid by direct interaction with
phospholipids, thus facilitating the mechanism of respiration
(Weaver, 1997; Johansson, 1998; Schürch et al., 2010). However,
both fractions are essential for surfactant functionality (Chroneos
et al., 2010). The physiological significance of SPs is underlined
by the severity of the natural course of conditions secondary
to surfactant deficiency or dysfunction, for example respiratory
distress syndrome of the (prematurely) newborn. In premature
infants, type II epithelial cells, which are the main source
of pulmonary surfactant, are not yet fully differentiated and
therefore cannot produce sufficient amounts of the rheologically
active compund. This condition results in RDS of the premature
infant (Whitsett, 2014). Until 1970, RDS was a mostly lethal
condition leading to respiratory failure regardless of the degree
of prematurity. Animal models of RDS provided insight
into surfactant physiology and revealed the curative potential
of intratracheal surfactant replacement therapy (Enhörning
and Robertson, 1972). As a consequence of this, surfactant
replacement was succesfully introduced as the gold standard
therapy of RDS, which significantly reduced mortality of the
disease (Kendig et al., 1991).
Besides the lungs, SPs are further present at numerous barriers
between distinct physiological compartments, for example in the
gingiva epithelium of the oral cavity (Schicht et al., 2015), in
the endometrium adjacent to the uterine cavity (Yadav et al.,
2011) and in the testes corresponding the anatomical location
of the blood-testis-barrier (Beileke et al., 2015). Considering the
well investigated roles of SPs at the interface between tissue
and avleolar fluid in the lungs and their remarkable expression
pattern at other interfaces in the body, it can be assumed that
SPs generally have a specific scope of functions at physiological
boundaries.
In addition to the previously given interfaces, SPs are inherent
proteins of the central nervous system (CNS) being abundant
at the sites of the blood-brain barrier (BBB) and blood-CSF
barrier (BSCFB; Schob et al., 2013). SP-A and SP-C appear in
the CNS already during embryonic development, resembling the
appearance pattern in the lungs, whereas SP-B and SP-D do
not appear in the CNS until birth (Schob et al., 2016a). On
a cellular level SPs of the CNS are produced within astrocytic
feet processes surrounding parenchymal vessels, in the choroid
plexus and by ventricular ependymal cells to finally be released
into the CSF (Schob et al., 2016a). With reference to the well
known effects of SPs on the physicochemical properties of
the alveolar fluid, an important role of SPs for CSF rheology
is presumable. This hypothesis is corroborated by a recent
work, which demonstrated that SP concentrations in CSF are
significantly altered in patients suffering from hydrocephalic
conditions (Schob et al., 2016b). Hydrocephalus is one of
the most challenging neurosurgical conditions to treat; for
the past centuries, different pathophysiological concepts and
discoveries lead to a yet incomplete understanding of the genesis
of this entity (Preuss et al., 2013). Diagnostics and therapy
until today still focus on ventricular enlargement; however,
underlying pathomechanisms and counterregulatory processes
are not sufficiently known (Preuss et al., 2013). To better
understand hydrocephalic conditions on a molecular level and
develop new, targeted therapeutic strategies, further insight in
the relationship between disease-related morphological changes
of the inner CSF spaces and alterations of rheologically active SPs
in the CSF is elementary.
Therefore the aim of the present study was to use reliable,
magnetic resonance imaging (MRI)-derived measurements
(Evans’ Index (Ragan et al., 2015) and the newly established
lateral ventricles area index (LVAI), reflecting enlargement of
the brain ventricles, to investigate the association between CSF
concentrations of rheologically important SPs and dilatation of
the inner CSF spaces.
MATERIALS AND METHODS
This is an institutional review board (Ethikkommission
Universität Leipzig Az 330-13-18112013) approved study with
retrospective design.
Patients
Inclusion Criteria
Patients were included in the hydrocephalus group if the
diagnostic criteria for aqueductal stenosis (AQS), acute
hydrocephalus (AH) or normal pressure hydrocephalus
(NPH) were met. Patients were included in the control group if
evidence of neurological disorders (clinical, neuroimaging and
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CSF examination) was absent. To be included in either group,
MRI and CSF samples had to be available in addition to the
clinical data.
If signs of infection or other inflammatory or autoimmune
diseases were present, the patient was not included in the study.
Also, evidence for blood brain barrier breakdown with leakage of
serum proteins into the CSF was an exclusion criterium for both
groups.
A total of 96 individuals was examined. All patients or
caregivers gave their informed consent for the scientific use of
CSF-samples, clinical and radiological data. Informed consent
was given in writing. CSF specimens of 41 subjects without
evidence of neurological pathologies were used as a control
group. Those specimens were obtained during a diagnostic
workup that necessitated CSF examination after lumbar puncture
(e.g., exclusion of subarachnoid hemorrhage, demyelinating
disease, meningitis). Furthermore, CSF samples were obtained
from 55 patients finally diagnosed with hydrocephalus in the
context of their diagnostic workup.
Hydrocephalus patients were categorized into the following
subgroups after the review of patient records and brain imaging:
AQS, AH (excluding AQS) and NPH. Twenty-one patients
with narrowed or obstructed mesencephalic aqueduct and
corresponding enlargement of the lateral and III. ventricles
in cranial imaging were classified as AQS (Cinalli et al.,
2011; Rodis et al., 2016). Nineteen patients exhibiting Hakim’s
triad (gait disturbance, urinary incontinence, dementia) and
morphological alterations in cranial MRI (cMRI) typical for
NPH (ventriculomegaly and tight convexity sulci in combination
with enlarged Sylvian fissures) were included after standardized
clinical (Mahr et al., 2016) and radiological examination
(Weerakkody et al., 2011; Preuss et al., 2013; Lieb et al., 2015).
The group of AH patients consisted of 15 individuals and was
a heterogenous group with AH of different pathophysiologies:
posthemorrhagic, postinfectious and idiopathic hydrocephalus
without radiological proof of occlusion of ventricular CSF
outflow (formerly classified as communicating hydrocephalus).
All AH patients presented signs of elevated intracranial pressure
(Freeman, 2015). Table 1A gives an overview of the demographic
data of hydrocephalic patients and the control group. Table 1B
summarizes the demographical data of the hydrocephalic
subgroups.
Determination of Surfactant Protein
Concentrations in CSF
SP concentrations were quantified using enzyme-linked
immunosorbent assays (ELISA) according to the manufacturer’s
TABLE 1A | Synopsis of demographic data of hydrocephalic patients vs.
controls.
Control group Hydrocephalic patients
n 41 55
Age in years 41.4 38.3
(mean, range) 2–84 <1–84
Sex (female/male) 17/14 27/28
TABLE 1B | Synopsis of demographic data of investigated hydrocephalus
subgroups.
AH AQS NPH
n 15 21 19
Age in years 25 21.2 67.7
(mean, range) <1–75 <1–65 31–84
Sex (female/male) 9/6 12/9 6/13
AH, acute hydrocephalus; AQS, aqueductal stenosis; NPH, normal pressure
hydrocephalus.
manual. Commercially available ELISA kits (USCN, Wuhan,
China) were used for quantification of SP-A (E90890Hu, ELISA
Kit for Surfactant Associated Protein A), SP-B (E91622Hu,
ELISA Kit for Surfactant Associated Protein B), SP-C
(E91623Hu, ELISA Kit for Surfactant Associated Protein C)
and SP-D (E91039Hu, ELISA Kit for Surfactant-Associated
Protein D) in CSF samples. The analysis was performed
using a microplate spectrophotometer (ELISA-reader) at a
wavelength of 450 nm and a reference wavelength of 405 nm
for absorbance measuring. Surfactant protein concentrations
in ng/ml CSF were calculated by comparison between standard
series and the determined values of antigen concentration
(protein concentration) according to the manufacturer’s
manual.
Magnetic Resonance Imaging
In all patients cMRI was performed by using either a
1.5 T device (Magnetom Symphony, Siemens/Germany;
Intera, Philips/Netherlands or Achieva, Philips/Netherlands)
or 3 T device (Trio Tim, Siemens/Germany). The
imaging protocols differed between the investigated
individuals depending on the initially suspected diagnosis.
All imaging protocols included an axial and sagittal
T2 weighted (T2w) turbo spin echo sequence (TSE)
as minimal imaging requirements, being necessary for
evaluation of Evans’ Index/LVAI and identification of AQS
or AH.
Determination of Ventricular
Enlargement—Evaluation of Evans’ Index
and LVAI
Image analysis was performed by a neuroradiologist (UQ) with
15 years of radiological experience.
The Evans’ Index was determined using OsiriX lite software as
follows: maximal width of the ventricular frontal horns divided
by the maximal transverse width of the cranium (Evans, 1942;
Ambarki et al., 2010).
The LVAI was estimated as follows: the axial section
showing the maximal area of the lateral ventricles (frontal
and occipital horns) was identified. The area of both frontal
and occipital horns—the maximal lateral ventricular area—was
quantified within this section using the area measurement
function in OsiriX lite. The total intracranial (intradural)
area in the same axial section was calculated, respectively.
Finally, the index was calculated as follows: maximal lateral
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FIGURE 1 | (A–D) Demonstrates estimation of Evan’s Index and lateral ventricles area index (LVAI) on axial T2 weighted (T2w) magnetic resonance imaging (MRI)
sections.
ventricular area divided by the corresponding intradural area.
Figures 1A–D exemplarily demonstrate estimation of Evans’
Index and LVAI.
Statistical Analysis
For statistical analysis the SPSS statistical software package was
used (SPSS 23, SPSS Inc., Chicago IL, USA). Collected data
was evaluated by means of descriptive statistics (mean, standard
deviation, range). Comparison of CSF-SP concentrations, Evans’
Index and LVAI between hydrocephalic patients and controls as
well as between the hydrocephalic subsets (acute hydrocephalic
conditions (AQS + AH) and NPH) and controls were performed
by means of ANOVA and—for the latter—Dunnett’s T-test
as a post hoc algorithm. For Dunnett’s test the control
group served as reference group for the hydrocephalic subsets.
p-values < 0.05 were taken to indicate statistical significance
in all instances. Spearman’s correlation coefficient was used to
analyze the association between Evans’ Index, LVAI, age and
CSF-SP concentrations.
RESULTS
The acquired data was analyzed in three subsequent steps:
(i) CSF-SP concentrations and indices of ventricular dilatation
(Evans’ Index and LVAI) were determined for the whole
collective in order to elucidate whether there is a general
association of SP concentration and ventricular enlargement.
(ii) Calculations were performed once more after separation
into two subgroups—all hydrocephalic patients and healthy
controls—to corroborate the gathered findings by comparing
changes in SP concentrations between individuals with and
without reliably proven ventricular enlargement. (iii) The
hydrocephalic subgroup was further devided into etiological
subsets—acute hydrocephalic conditions (AQS plus AH) vs.
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NPH—in order to challenge the previously reported exceptions
of the rather chronic hydrocephalic disease NPH regarding the
differences of SP concentration in the CSF.
Overall Collective
The calculated CSF-SP concentrations (mean ± standard
deviation) over all investigated subjects were as follows:
SP-A = 0.71 ± 0.58 ng/ml, SP-B = 0.18 ± 0.43 ng/ml,
SP-C = 0.89± 0.77 ng/ml and SP-D = 7.4± 5.4 ng/ml (Table 2).
Analysis of cMRI of all subjects revealed the following results
(mean values± standard deviation): Evans’ Index = 0.37± 0.11,
LVAI = 0.18 ± 0.15. Table 4 compares CSF-SP concentrations
and indices of ventricular enlargement between hydrocephalic
patients and the control group.
Subsequently, correlation analysis between CSF-SP
concentrations and cMRI derived measures of ventricular
enlargement (Evans’ Index, LVAI) was performed. As shown
in Table 3; Figures 2A–D, SP-A and SP-C correlated in a
statistically significant manner with Evans’ Index and LVAI
(SP-A + Evans’ Index: r = 0.388, p < 0.001, SP-A + LVAI:
r = 0.352; SP-C + Evans’ Index: r = 0.392, p < 0.001 SP-C +
LVAI: r = 0.471, p < 0.001). However, correlation of SP-C was
stronger with LVAI compared to Evans’ Index, as shown by the
higher correlation coefficient (r). Interestingly, SP-D showed
a statistically significant correlation with LVAI (r = 0.233,
p = 0.025, graphically demonstrated in Figure 2E), but not with
Evans’ Index. SP-B did not show any correlation with either
index.
Hydrocephalic and Control Subgroups
CSF-SP concentrations as well as the two dilatation indices
are being compared. ANOVA revealed statistically significant
differences regarding CSF-SP concentrations of SP-A (p< 0.001)
and SP-C (p < 0.001) between hydrocephalic patients and
TABLE 2 | Overview of CSF-SP concentrations and measures of
ventricular enlargement (Evans’ Index, lateral ventricles area index (LVAI)
in all investigated individuals.
Mean ± SD Range
SP-A (ng/ml) 0.71 ± 0.58 0.03−2.34
SP-B (ng/ml) 0.18 ± 0.43 0.0−1.92
SP-C (ng/ml) 0.89 ± 0.77 0.10−5.18
SP-D (ng/ml) 7.4 ± 5.4 0.00−38.03
Evans’ Index 0.37 ± 0.11 0.09−0.73
LVAI 0.18 ± 0.15 0.01−0.79
TABLE 3 | Results of the correlation analysis between measures of
ventricular enlargement (Evans’ Index, LVAI) and CSF-SP levels of all
investigated individuals.
SP-A SP-B SP-C SP-D
Evans’ Index r = 0.388 r = 0.038 r = 0.392 r = 0.168
p = <0.001 p = 0.722 p = <0.001 p = 0.107
LVAI r = 0.352 r = 0.041 r = 0.471 r = 0.233
p = 0.001 p = 0.702 p = <0.001 p = 0.025
Underlined results indicate statistical significance.
control subjects. The findings are graphically summarized
in Figures 3A,B. No significant differences were found for
SP-B and SP-D, although a trend was delineable for SP-D
(p = 0.087).
Evans’ Index and LVAI showed statistically significant
differences between hydrocephalic patients and control subjects
by means of ANOVA (both p< 0.001), Figures 3C,D summarize
the findings graphically.
Different Hydrocephalic Subsets—Acute
Hydrocephalic Conditions (AQS Plus AH)
and (Chronic) NPH vs. Controls
Table 5 shows the comparative descriptive statistics of the acute
hydrocephalic conditions subset vs. the NPH subset. For reasons
of better comparability control values were also included in
Table 5.
ANOVA, comparing the acute hydrocephalic conditions
subset, the NPH subset and the control group as three equal
groups regarding CSF-SP concentrations and measures of
ventricular enlargement revealed the following results: SP-A,
SP-C, SP-D, Evans’ Index and LVAI, but not SP-B were
significantly different between the groups (SP-A: p < 0.001,
SP-C: p < 0.001, SP-D: p = 0.046, Evans’ Index: p < 0.001,
LVAI: p < 0.001). Figures 4A–C graphically demonstrate
differences in CSF-SP levels between the investigated
subsets, Figures 4D,E show differences regarding Evans’
Index and LVAI.
Dunnett’s test gave the following results: values of SP-A
(p < 0.001), SP-C (p < 0.001), SP-D (p = 0.040), Evans’ Index
(p < 0.001) and LVAI (p < 0.001) were different in the acute
hydrocephalic conditions subset compared to the control group.
Regarding the NPH subset, Dunnett’s test showed the following
results: significant differences in comparison to the control
group were identified for Evans’ Index (p < 0.001) and LVAI
(p < 0.001). SP-A showed a clear trend, but the difference in
SP-A levels between NPH subset and control group did not reach
statistical significance (p = 0.052).
It was demonstrated that both hydrocephalic subsets,
the acute hydrocephalic conditions subset and the NPH
subset, exhibit significant ventricular enlargement compared
to the control group. However, only the acute hydrocephalic
conditions subset revealed significant differences in CSF-SP
concentrations compared to controls. To further investigate
the association between enlargement of the inner CSF spaces
and SP-CSF concentrations in both hydrocephalic subsets,
ANOVA (regarding measures of ventricular enlargement and
CSF-SP concentrations) was performed including only both
hydrocephalic subsets.
As expected, measures of ventricular dilatation did not
reveal statistically significant differences between the acute
hydrocephalic conditions subset and the NPH subset. In
contrary, CSF-SP concentrations were significantly different in
the NPH subset compared to the acute hydrocephalic conditions
subset (SP-A: p = 0.046, SP-C: p = 0.008). Figures 5A,B
graphically demonstrate differences in CSF-SP concentrations
between the NPH subset and the acute hydrocephalic conditions
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FIGURE 2 | (A–E) Graphically demonstrates identified correlations between measures of ventricular enlargement (Evans’ Index and LVAI) and cerebrospinal fluid
(CSF)-Surfactant protein (SP) concentrations (SP-A, SP-C and SP-D).
subset, Figures 5C,D demonstrate comparable values (no
differences) of ventricular enlargement in both subsets.
Additionally, correlation analysis of ventricular dilatation
indices and CSF-SP concentrations was performed in both
hydrocephalic subsets (the NPH subset and the acute
hydrocephalic conditions subset). Spearman correlation
analysis yielded the following results: in both subsets there
was a highly significant correlation between SP-A and SP-C
concentrations with both dilatation indices. The acute subset
even showed a significant correlation of SP-D with both
Evans’ Index and LVAI, which was not detectable in the
NPH subset.
In the acute hydrocephalic conditions subset values were as
follows: SP-A with Evans’ Index (r = 0.458, p < 0.001) and
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FIGURE 3 | Graphically demonstrates significant differences between the control group and all hydrocaphalic patients identified by means of
ANOVA. (A,B) Show differences in CSF concentrations of SP-A and SP-C. (C,D) Show differences in measures of ventricular enlargement (Evans’ Index and LVAI).
Circles (◦) are used to denote outliers that are farther than 1.5 interquartile ranges, yet closer than 3 interquartile ranges away from the nearer edge of the box. Little
stars (∗) indicate outliers that are farther than 3 interquartile ranges away from the nearer edge of the box.
TABLE 4 | Comparison of CSF-SP levels, Evans’ Index and LVAI between
hydrocephalic patients and controls.
Hydrocephalic patients (n = 55) Control group (n = 41)
Mean ± SD Range Mean ± SD Range
SP-A (ng/ml) 0.93 ± 0.64 0.03−2.34 0.37 ± 0.21 0.05−0.95
SP-B (ng/ml) 0.14 ± 0.33 0.00−1.41 0.24 ± 0.53 0.00−1.92
SP-C (ng/ml) 1.22 ± 0.88 0.10−5.18 0.49 ± 0.26 0.12−1.07
SP-D (ng/ml) 8.16 ± 6.74 0.00−38.03 6.20 ± 2.04 2.81−9.85
Evans’ Index 0.43 ± 0.09 0.28−0.73 0.28 ± 0.07 0.09−0.53
LVAI 0.26 ± 0.14 0.04−0.79 0.07 ± 0.07 0.01−0.38
LVAI (r = 0.433, p = 0.001), SP-C with Evans’ Index (r = 0.457,
p < 0.001) and LVAI (r = 0.519, p = 0.001) and SP-D with
Evans’ Index (r = 0.241, p = 0.038) and LVAI (r = 0.271,
p = 0.019).
In the NPH subset values were as follows: SP-A with Evans’
Index (r = 0.438, p = 0.001) and LVAI (r = 0.326, p = 0.013)
and SP-C with Evans’ Index (r = 0.365, p < 0.007) and LVAI
(r = 0.315, p = 0.017).
Finally, the relation of both dilatation indices was examined
more closely. Evans’ Index correlated well with LVAI (r = 0.884,
p < 0.0001) in the overall population, the association between
both parameters is graphically demonstrated in Figure 6A.
Analyzing the data exclusively from hydrocephalic patients the
correlation was as follows: r = −0.357, p = 0.011. Analyzing the
data exclusively from the control group the correlation was as
follows: r =−0.327, p = 0.039.
As an additional finding, SP-C showed a clear inverse
correlation with age when analyzing data from all investigated
subjects (r =−0.343, p = 0.001; Figure 6B).
DISCUSSION
Our study is the first to report the relation between
dilatation of the brain ventricles and SP concentration
in CSF.
According to the literature, SPs fulfill a variety of
organ-specific functions in various extrapulmonary tissues
(Bräuer et al., 2007a,b; Snegovskikh et al., 2011). Besides
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TABLE 5 | Comparison of CSF-SP levels, Evans’ Index and LVAI between hydrocephalic subsets—acute hydrocephalic conditions (AQS plus AH) and
NPH vs. the control group.
Acute hydrocephalic conditions (n = 36) Control group (n = 41) NPH (n = 19)
Mean ± SD Range Mean ± SD Range Mean ± SD Range
SP-A (ng/ml) 1.05 ± 0.69 0.03−2.34 0.37 ± 0.21 0.05−0.95 0.69 ± 0.45 0.17−1.76
SP-B (ng/ml) 0.10 ± 0.29 0.00−1.20 0.24 ± 0.53 0.00−1.92 0.22 ± 0.39 0.00−1.41
SP-C (ng/ml) 1.45 ± 0.99 0.10−5.18 0.49 ± 0.26 0.12−1.07 0.76 ± 0.34 0.13−1.46
SP-D (ng/ml) 9.10 ± 7.75 0.00−38.03 6.20 ± 2.04 2.81−9.85 6.38 ± 3.83 0.00−13.98
Evans’ Index 0.45 ± 0.11 0.28−0.73 0.28 ± 0.07 0.09−0.53 0.41 ± 0.05 0.33−0.51
LVAI 0.28 ± 0.16 0.04−0.79 0.07 ± 0.07 0.01−0.38 0.23 ± 0.09 0.09−0.38
their important role as specialized antibodies of the innate
immune system (Palaniyar, 2010), SPs support the stability
and rheology of fluids at interfaces in the body (Schicht et al.,
2015).
Concerning this matter it is of great interest that SPs have
been identified as inherent proteins of the CNS, synthesized and
secreted by choroid plexus and ependymal cells, which are also
the major sites of CSF production (Schob et al., 2013, 2016a).
Also in some, but not all hydrocephalic conditions SPs
were shown to be significantly elevated in the CSF of patients
compared to normal subjects (Schob et al., 2016b). In detail it was
demonstrated that SP-A and SP-C levels (in contrary to SP-B and
SP-D) in the CSF were significantly higher in patients suffering
from rather acute hydrocephalic conditions, but not in patients
suffering from NPH, who also exhibit significant enlargement of
the inner CSF spaces. This raises the question after a possible
relationship between the phenomena of elevated CSF-SP levels
and ventricular enlargement.
Dilatation of the brain ventricles in adults, being the
hallmark of hydrocephalic conditions, can at best be diagnosed
and monitored by use of cross sectional imaging. Different
approaches and indices for quantification of ventricular
enlargement exist. Ventricular dilatation is most accurately
estimated using volumetric, three dimensional approaches
(Toma et al., 2011; Ishii et al., 2013; Ragan et al., 2015).
However, to reliably perform volumetric measurements
isovoxel 3D datasets have to be acquired in MRI (Chaarani et al.,
2014). Unfortunately, 3D datasets are not included in most MRI
protocols intended for clinical routine purposes in our hospital,
since they are relatively time consuming and prone to motion
artifacts. Patients suffering from neurological conditions often
cannot lay still during a long lasting MRI investigation for they
often present with movement and shaking troubles. Therefore,
3D datasets were not available in most cases for our study. As a
consequence of that we chose to evaluate ventricular dilatation
using an existing, uni-dimensional approach (Evans’ Index)
as well as a self-designed, hereby introduced two-dimensional
approach (LVAI).
The Evans’ Index is an easy, rapid and robust linear
method not requiring any specialized software (Ambarki et al.,
2010). It displays the ratio of maximum width of the frontal
horns of the lateral ventricles and the maximal diameter of
the skull measured in the same axial section in a CT or
MRI scan. However, Toma et al. (2011) discussed that Evans’
Index is not an ideal method for estimation of ventricular
enlargement, for it can vary significantly in a patient with NPH,
depending on the level of the brain scan image at which the
frontal horns and maximal inner skull diameters are measured.
Nevertheless, Evans’ Index is still used in clinical routine
(Lieb et al., 2015) and has been shown to correlate excellently
with ventricular volume (Reinard et al., 2015). Despite the
aforementioned, Evans’ Index does not account for asymmetrical
or uneven enlargement of the lateral ventricles (Ragan et al.,
2015).
To reduce possible bias in the evaluation of ventricular
enlargement secondary to asymmetrical or uneven ventricular
dilatation, we designed the two-dimensional LVAI, which shares
common features with the (like Evan’s Index uni-dimensional)
frontal occipital horn ratio (O’Hayon et al., 1998). As shown by
Chaarani et al. (2013), two-dimensional estimations of the lateral
ventricles can be used reliably to assess ventricular volume, if 3D
images are not available for reasons discussed above.
Evans’ Index and LVAI revealed an excellent correlation in
our study, indicating that both reflect ventricular enlargement.
This is further underlined by the results of ANOVA, showing
that Evans’ Index and LVAI were significantly different in
hydrocephalus patients compared to the healthy control group.
In the overall collective, SP-A and SP-C revealed clear
correlations with Evans’ Index, which corresponds well to the
findings of our previously published study (Schob et al., 2016b).
As anticipated, SP-A and SP-C also correlated well with the
LVAI. In fact, the correlation of SP-C and LVAI revealed to be
even superior compared to Evans’ Index. Also, SP-D showed a
moderate correlation with LVAI, but not with Evans’ Index. This
might indicate that LVAI indeed measures additional features of
ventricular enlargement, which are not accounted for by Evans’
Index.
As mentioned above, one of the major findings of our
previous study (Schob et al., 2016b) was a significant increase of
SP-A and SP-C in diseases with ventricular enlargement—with
the exception of NPH. This challenged the formulated hypothesis
that ventricular enlargement as such is associated with increased
concentrations of these two SPs, and may instead be limited
to acute events. Yet the extent of ventricular enlargement in
these cases had not been determined. Analyzing the current
data, we found comparably increased ventricular width in both
acute and NPH subsets compared to the control population.
Again, SP-A and SP-C showed significantly elevated levels in the
acute hydrocephalic conditions, but no significant elevation in
NPH (whereas SP-A showed a clear trend of increase in NPH
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FIGURE 4 | (A–E) Graphically demonstrates significant differences between the control group, the acute hydrocephalic conditions subset (composed of acute
hydrocephalus (AH) and aqueductal stenosis (AQS) patients) and the normal pressure hydrocephalus (NPH) subset identified by means of ANOVA. (A–C) Show
differences in CSF concentrations of SP-A, SP-C and SP-D. (D,E) Show differences in measures of ventricular enlargement (Evans’ Index and LVAI). Circles (◦) are
used to denote outliers that are farther than 1.5 interquartile ranges, yet closer than 3 interquartile ranges away from the nearer edge of the box. Little stars (∗)
indicate outliers that are farther than 3 interquartile ranges away from the nearer edge of the box.
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FIGURE 5 | Graphically demonstrates significant differences between the acute hydrocephalic conditions subset (composed of AH and AQS
patients) and the NPH subset identified by means of ANOVA. (A,B) Show differences in CSF concentrations of SP-A and SP-C. (C,D) Show that there are no
significant differences in measures of ventricular enlargement (Evans’ Index and LVAI) between both hydrocephalic subsets. Circles (◦) are used to denote outliers that
are farther than 1.5 interquartile ranges, yet closer than 3 interquartile ranges away from the nearer edge of the box.
FIGURE 6 | (A,B) Graphically demonstrates the idientfied correlation between both measures of ventricular enlargement (Evans’ Index and LVAI) as well as the
inverse correlation between SP-C in CSF and age.
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vs. the control group). Yet, the measured SP concentrations
correlated well with both dilatation indices in every subset,
including NPH. This corroborates an indeed existing general
relation between ventricular width and SP-concentration, even
if the mere concentrations do not reflect significant alterations
in case of NPH. It may be speculated that, as part of probable
compensatory mechanisms due to a prolonged course of the
disease, the SP-concentrations are not as notably elevated in
NPH, resulting in the delineable trend, but not statistical
significance.
Surprisingly, SP-C revealed a clear inverse correlation with
age in our present study. This association was identifiable
when calculating the Spearman correlation coefficient including
hydrocephalus patients only, including the control group only
and including all investigated individuals. This might indicate
that SP-C generally decreases in the CSF with growing age.
CONCLUSION
The present study confirmed a clear correlation between SP-A
and SP-C in the CSF with enlargement of the inner CSF
spaces. Furthermore, a moderate correlation between SP-D in
CSF with ventricular enlargement was identified by using a
more accurate, area measurement based approach compared
to the simple, linear approach. This possibly indicates that
SP-D is also differently regulated in hydrocephalic conditions,
but in a more subtle manner than SP-A and SP-C. In
conclusion, SPs clearly play an important role for CSF rheology.
CSF rheology is profoundly altered in hydrocephalic diseases,
however, diagnosis and therapy of hydrocephalic conditions
are still almost exclusively based on ventricular enlargement.
Until now it was unclear, whether the stage of the disease, as
represented by the extent of ventricular dilatation, is somehow
related to the changes of SP levels in the CSF. Our study is
the first to provide evidence that aggravated ventriculomegaly
is accompanied by enhanced changes of rheologically active
compounds in the CSF and therefore introduces completely new
aspects for hydrocephalus testing and conservative therapeutic
approaches.
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